)
Gravitas: Potential cure for blood disorders approved in UK
Britain approves world's first gene therapy casgevy for sickle cell disease and Thalassemia. The UK drug regulator approves medicine for patients who are 12 years old and over.
Britain approves world's first gene therapy casgevy for sickle cell disease and Thalassemia. The UK drug regulator approves medicine for patients who are 12 years old and over.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)